To the Editor
- PMID: 32852465
- DOI: 10.1097/GME.0000000000001624
To the Editor
Comment in
-
In Reply.Menopause. 2020 Sep;27(9):1097-1098. doi: 10.1097/GME.0000000000001625. Menopause. 2020. PMID: 32852466 No abstract available.
Comment on
-
The Women's Health Initiative trials of menopausal hormone therapy: lessons learned.Menopause. 2020 Aug;27(8):918-928. doi: 10.1097/GME.0000000000001553. Menopause. 2020. PMID: 32345788 Clinical Trial.
References
-
- Manson JE, Bassuk SS, Kaunitz AM, Pinkerton JV. The Women's Health Initiative trials of menopausal hormone therapy: lessons learned. Menopause 2020; 27:918928.
-
- NAMS Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause 2017; 24:728753.
-
- Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321333.
-
- Utian WH. Personal perspective. NIH and WHI – time for a mea culpa and steps beyond. Menopause 2007; 14:10561059.
-
- Utian WH. A decade post WHI, menopausal hormone therapy comes full circle – need for independent commission. Climacteric 2012; 15:320325.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical